Replies to post #185842 on Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Do you think IPIX will be able to deliver top-line results for the four Phase 2 trials in the next 12 months with available financing?

[djs7]

Bunny,

Please break the costs down for us of what it may cost to finish
the following mid-stage trials:

Part I for Bunny

1. The final 20% enrollment for Prurisol Phase 2B
2. The possibly 50% remaining enrollment for Brilacidin-OM Phase 2
3. The completion of the currently active final 17th patient for Brilacidn-UP?
4. The completion of Kevetrin-Ovarian cancer 10 patient trial?

Part II for Bunny

Can 3 out of 4 mid-stage trials be completed within 6 months?

We know Brilacidin-UP will be completed early July.

Your comments may seem to indicate the Market knows all the answers as it has ears and eyes to the meetings and multiple CDA documents being exchanged between Big Pharma and Innovation Pharmaceuticals referred to in the Conference Call last week. Some Big Pharmas interested in one of the drugs, others interested in a combination of drugs (via the Conference Call)

Can you offer any enlightenment to the above content of questions in regards to company IPIX with currently running 4 mid stage trials and an antibiotic with a completed phase 2B that was equivalent to the former Cubist Pharmaceutical's Daptomycin that had 1 billion or so in sales (probably accounted for >= 80% of Cubist Pharmaceutical sales) before it was bought out by Merk for 9.5 billion?????

https://seekingalpha.com/news/1503931-cubist-q4-revenues-plus-22-percent-cubicin-annual-sales-top-1b [show]

Of course this is all voluntary on your part!!!

Thanks in advance.